Youguang Pu

963 total citations
29 papers, 750 citations indexed

About

Youguang Pu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Youguang Pu has authored 29 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Youguang Pu's work include RNA modifications and cancer (14 papers), MicroRNA in disease regulation (11 papers) and Cancer-related molecular mechanisms research (11 papers). Youguang Pu is often cited by papers focused on RNA modifications and cancer (14 papers), MicroRNA in disease regulation (11 papers) and Cancer-related molecular mechanisms research (11 papers). Youguang Pu collaborates with scholars based in China and United States. Youguang Pu's co-authors include Fangfang Zhao, Shanbao Cai, Haiyan Wang, Wenjing Cai, Xianghui Meng, Lei Lv, Daming Zhang, Chunbao Zang, Liting Qian and Yinghua He and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecular Cancer.

In The Last Decade

Youguang Pu

28 papers receiving 746 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Youguang Pu 605 539 80 73 68 29 750
Deyao Wu 615 1.0× 587 1.1× 57 0.7× 65 0.9× 70 1.0× 19 748
Kang Huang 462 0.8× 431 0.8× 41 0.5× 78 1.1× 92 1.4× 16 582
Floriana Forzati 738 1.2× 361 0.7× 48 0.6× 75 1.0× 77 1.1× 22 848
Elena Jelezcova 593 1.0× 422 0.8× 42 0.5× 37 0.5× 99 1.5× 7 689
Paula López-Serra 486 0.8× 249 0.5× 67 0.8× 30 0.4× 64 0.9× 6 572
Mohammadreza Hajjari 755 1.2× 738 1.4× 44 0.6× 40 0.5× 52 0.8× 46 896
Daniela Schwarzenbacher 493 0.8× 425 0.8× 28 0.3× 56 0.8× 101 1.5× 14 625
Stine Jørgensen 689 1.1× 413 0.8× 35 0.4× 33 0.5× 109 1.6× 9 792
Shi-Jiang Deng 696 1.2× 654 1.2× 69 0.9× 45 0.6× 168 2.5× 14 874

Countries citing papers authored by Youguang Pu

Since Specialization
Citations

This map shows the geographic impact of Youguang Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youguang Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youguang Pu more than expected).

Fields of papers citing papers by Youguang Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youguang Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youguang Pu. The network helps show where Youguang Pu may publish in the future.

Co-authorship network of co-authors of Youguang Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Youguang Pu. A scholar is included among the top collaborators of Youguang Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youguang Pu. Youguang Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wei, Ran, Fangfang Zhao, Lingsuo Kong, et al.. (2024). The antagonistic effect of FTO on METTL14 promotes AKT3 m6A demethylation and the progression of esophageal cancer. Journal of Cancer Research and Clinical Oncology. 150(3). 131–131. 1 indexed citations
3.
Zhao, Fangfang, Chao Wei, Youguang Pu, & Chunbao Zang. (2024). LAMTOR5-AS1 Regulates Chemotherapy-induced Oxidative Stress via the miR-34a-3p/SIRT1/HNF4A Axis in Osteosarcoma Cells. Current Medicinal Chemistry. 32(30). 6633–6645. 1 indexed citations
4.
Kong, Lingsuo, Fei Gao, Xia Ran, et al.. (2023). Profiling the m6A-regulated RNA expression patterns and alternative splicing features in esophageal carcinoma. Genes & Diseases. 10(5). 1812–1815. 3 indexed citations
5.
Zhao, Fangfang, Ming‐Hua Xie, Zhenyu Li, et al.. (2022). FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells. Clinical & Experimental Metastasis. 39(4). 623–639. 14 indexed citations
6.
Zhao, Fangfang, Shuhan Liu, Chunbao Zang, et al.. (2022). A New Functional Gene, Zinc Finger Protein 485 (ZNF485), is Involved in Bladder Cancer Proliferation. Bladder Cancer. 8(2). 165–177. 1 indexed citations
7.
Pu, Youguang, Chunbao Zang, Fangfang Zhao, et al.. (2021). LAMTOR5-AS1 regulates chemotherapy-induced oxidative stress by controlling the expression level and transcriptional activity of NRF2 in osteosarcoma cells. Cell Death and Disease. 12(12). 1125–1125. 25 indexed citations
8.
Wang, Haiyan, Fangfang Zhao, Shanbao Cai, & Youguang Pu. (2019). MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2. Journal of bone oncology. 17. 100241–100241. 18 indexed citations
9.
Zang, Chunbao, Fangfang Zhao, & Youguang Pu. (2019). LMX1B involved in the radioresistance, proliferation and migration of esophageal cancer cells. Biomedicine & Pharmacotherapy. 118. 109358–109358. 5 indexed citations
10.
Pu, Youguang, et al.. (2017). The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene. BMC Cancer. 17(1). 45–45. 56 indexed citations
11.
Zhao, Fangfang, et al.. (2017). MiR-20a-5p represses the multi-drug resistance of osteosarcoma by targeting the SDC2 gene. Cancer Cell International. 17(1). 100–100. 25 indexed citations
12.
Pu, Youguang, Fangfang Zhao, Haiyan Wang, & Shanbao Cai. (2017). MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene. Scientific Reports. 7(1). 44218–44218. 46 indexed citations
13.
Pu, Youguang, et al.. (2016). MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively. Clinical & Experimental Metastasis. 33(4). 359–372. 83 indexed citations
14.
Pu, Youguang, Qiyi Yi, Fangfang Zhao, et al.. (2016). MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene. Cancer Cell International. 16(1). 64–64. 43 indexed citations
15.
Jiang, Yuan, Liuwang Nie, Haifeng Li, et al.. (2015). The Historical Speciation of Mauremys Sensu Lato: Ancestral Area Reconstruction and Interspecific Gene Flow Level Assessment Provide New Insights. PLoS ONE. 10(12). e0144711–e0144711. 8 indexed citations
16.
Zhang, Zhengliang, et al.. (2015). Influences of keratinocyte growth factor - mesenchymal stem cells on chronic liver injury in rats. Artificial Cells Nanomedicine and Biotechnology. 44(8). 1810–1817. 7 indexed citations
17.
Deng, Hui, Lei Lv, Yang Li, et al.. (2014). The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(3). 520–528. 50 indexed citations
18.
Deng, Hui, Lei Lv, Yang Li, et al.. (2014). miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathway. Molecular Cancer. 13(1). 234–234. 75 indexed citations
19.
Lv, Lei, Yang Li, Hui Deng, et al.. (2014). MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene. Cancer Letters. 357(1). 105–113. 57 indexed citations
20.
Lv, Lei, Han‐Xiang Deng, Daming Zhang, et al.. (2014). The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression. Cell Death and Disease. 5(9). e1402–e1402. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deyao Wu Breakdown of academic impact, for papers by Kang Huang Breakdown of academic impact, for papers by Floriana Forzati Breakdown of academic impact, for papers by Elena Jelezcova Breakdown of academic impact, for papers by Paula López-Serra Breakdown of academic impact, for papers by Mohammadreza Hajjari Breakdown of academic impact, for papers by Daniela Schwarzenbacher Breakdown of academic impact, for papers by Stine Jørgensen Breakdown of academic impact, for papers by Shi-Jiang Deng
Rankless by CCL
2026